Navigation Links
The Quigley Corporation to Announce Second Quarter Results and Host Audio Web Cast
Date:7/30/2009

DOYLESTOWN, Pa., July 30 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com today announced it will issue its second quarter results before market open on Wednesday, August 5, 2009.

Ted Karkus, Chairman and CEO, will provide a Company overview including a review of recent activities and second quarter results on a conference call which will be web cast on The Quigley Corporation's web site, (www.quigleyco.com), at 10:00 AM (ET) that morning.

A replay of the conference call will be available for 30 days on the Company web site.

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY) (http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R) family of lozenges, gums and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries including Quigley Manufacturing Inc., which consists of an FDA approved facility to manufacture COLD-EEZE(R) lozenges and fulfill other contract manufacturing opportunities, and Quigley Pharma Inc., (
'/>"/>

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study
2. Ted Karkus Named CEO of The Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer
3. Dr. Richard Rosenbloom Resumes Services To The Quigley Corporations Pharma Subsidiary
4. Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation
5. Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation; Ted Karkus Elected Chairman of the Board
6. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
7. Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation
8. Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Companys Latest Announcement
9. The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
10. Judge Rejects Quigleys Claims - Karkus Director Candidates Prevail in Federal Court
11. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Quincy Bioscience, one ... States, promotes National Self-Improvement Month this ... individuals should have access to self-improvement resources, especially ... The demand for products that preserve health is ... before. For over six years, Quincy Bioscience has ...
(Date:9/22/2014)... Orange, NJ. September 22, 2014. Kessler researchers have ... a 10-week psychoeducational wellness program in people with ... mood, overall mental health, perceived stress, and pain. ... group for individuals living with MS: Description and ... 3 in the International Journal of MS ...
(Date:9/22/2014)... UK (PRWEB) September 22, 2014 The ... in the recent years. The statistically important data received ... safety of cancer vaccines. The primary challenge to the ... information about the exact mechanism of how a human’s ... to various results in different individuals owing to known ...
(Date:9/22/2014)... The Workgroup for Electronic Data ... on the use of health IT to create ... its recent industry survey on the use of ... transactions adopted under the Health Insurance Portability and ... August 20 to September 5, which included 262 ...
(Date:9/22/2014)... 22, 2014 As concerns about ... power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) in gynecological surgeries ... detailing the continued use of uterine morcellation by ... specifically discouraged these procedures. According to The Wall ... cancer risks associated with power morcellators are overblown, ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4
... PHILADELPHIA, Pennsylvania, June 4 ... Updates Findings Related to Australian Sponsored,Publication Practices From ... leading international publisher of scientific, technical and,medical (STM) ... moved,to provide consistent internal guidelines for its pharmaceutical ...
... , FRANKLIN, Mass., June 4 PLC Systems Inc. (OTC ... vascular medical device-based technologies, today announced the appointment of Louis ... Brenner, currently Senior Vice President at AMAG Pharmaceuticals, Inc., fills ... seek re-election. , , Dr. Brenner, 39, brings to ...
... research that has suggested excess weight worsens disease , THURSDAY, ... may not worsen asthma, as many experts have thought, but ... manage the chronic condition. , Inhaled corticosteroids are the most ... with asthma, many of whom are overweight or obese. , ...
... June 4 Last night, the America,s Health Insurance ... Keystone Mercy Health Plan, Group Health Cooperative of South ... plans with innovative programs designed to improve the health ... on a tradition among health plans of working with ...
... Research Hospital(R) celebrated its 7th annual FedEx/St. Jude Angels & ... on May 16th, at the InterContinental Hotel in Miami, Florida. ... El Gordo y La Flaca presented Tommy and ... to children,s causes and for their contributions to the entertainment ...
... Finding could help those with potentially deadly conditions , ... your blood miraculously stops flowing and forms a scab ... down to the molecular level. , "The human body ... and bruises," study co-author Wesley P. Wong, a principal ...
Cached Medicine News:Health News:Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications 2Health News:Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications 3Health News:PLC Systems Announces Appointment of Louis Brenner, M.D. to Board of Directors 2Health News:Obesity May Dampen Response to Asthma Meds 2Health News:AHIP Foundation Announces 2009 Community Leadership Awards 2Health News:Photos: Tommy & Thalia Mottola Honored at 7th Annual FedEx/St. Jude Angels & Stars Gala 2Health News:Photos: Tommy & Thalia Mottola Honored at 7th Annual FedEx/St. Jude Angels & Stars Gala 3Health News:Researchers Detect Blood-Clotting Mechanism 2
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014 /PRNewswire/ ... knowledge leader in healthcare technology, media and telecommunications, ... innovation in China and ... Continua and BHG announced this new partnership during ... week in Washington, DC , ...
(Date:9/22/2014)... Sept. 22, 2014 Research and ... "Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, ... report to their offering. On ... ablation technologies market has been divided into eight ... cryotherapy, hydrothermal, and hydromechanical ablation technologies. The light/laser ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... As global food insecurity reaches all-time highs, Elanco seeks ... impact this growing crisis. Today, the company announced its ... a partnership with Heifer International. Elanco, ... global pharmaceutical corporation, is also dedicated to helping create ...
... IDEV Technologies, Inc. (IDEV) today announced the completion of ... evaluating the use of IDEV,s SUPERA® stent system for ... artery (SFA).  Enrollment was completed in May, making SUPERB ... The trial is a prospective, single-arm study of 258 ...
Cached Medicine Technology:Elanco Announces Commitment to Fight World Hunger 2Elanco Announces Commitment to Fight World Hunger 3IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment 2
... PW 41 is a powerful, compact ... washers/aspirators, with built-in vacuum and dispensing ... ,are user-adjustable, with vertical and horizontal ... level detectors on wash and waste ...
... LHW is a solid made, manual ... Separate valves for dispense and aspirate ... comes complete with a stand and ... can be used, as well as ...
... ELx50 is a fast and versatile automated strip ... manifold. It is a self contained and programmable ... fluidic delivery from the gentle dripping of a ... pressure delivery systems. ELx50/12V processes 1 x 12 ...
... throughput washer for high ... throughput system washer is ... powerful dispensing line and ... stronger, external vacuum source. ...
Medicine Products: